Poster-Quality of Life and Outcomes
October 25, 2021
Assessing Presence of MS-Related Symptoms As a Proxy for Disease Severity in Multiple Sclerosis Using Administrative Claims Data
Background: Healthcare claims data lack clinically relevant variables such as disease severity. Objectives: Assess multiple sclerosis...
Poster-Quality of Life and Outcomes
October 25, 2021
Clinical and Economic Impact of Employees Who Are Care Partners of Patients with Multiple Sclerosis
Background: Historically, there has been limited research on care partners of patients with multiple sclerosis (MS). Employers, health care...
Poster-Disease-modifying Therapy
October 25, 2021
Click-MS: Cladribine Tablets in Patients with Relapsing Multiple Sclerosis after Suboptimal Response to Prior Injectable Disease-Modifying Therapy (Interim Analysis 1)
Background: The efficacy and safety of cladribine tablets 3.5 mg/kg (cumulative dose over 2 years) have been shown in patients with...